Real-time nanopore transcriptomics enables early detection of expression changes and sample quality, offering a rapid, cost-effective strategy for experimental quality control and transcriptomic ...
Multicenter prospective validation of PanClaudinAI: An AI for predicting Claudin 18.2 from CT in pancreatic cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Gastrointestinal Cancers ...
Computational assessment identifies probe binding errors in a widely used commercial platform for spatial transcriptomics.
Endometrial cancer (EC) is one of the most common gynaecological malignancies in high-income countries and is associated with ...
Head and neck cancers display notable heterogeneity in their immune cell infiltrates, which reflect intricate spatial arrangements and dynamic networks of ...
Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...
Transcriptomic phenotyping offers mechanistic insight into adipocyte biology and metabolic disease. A signature of adipocyte ...
Unbiased DIA mass spectrometry quantified 5702 proteins, identifying 468 upregulated and 1296 downregulated proteins in MCL versus normal B cells, including strong CCND1 overabundance. Coordinated ...
BioSkryb Genomics and Tecan report that they have introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ whole genome and transcriptome single-cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results